BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30659870)

  • 1. Melanoma prognosis in the United States: Identifying barriers for improved care.
    Hopkins ZH; Moreno C; Carlisle R; Secrest AM
    J Am Acad Dermatol; 2019 May; 80(5):1256-1262. PubMed ID: 30659870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993.
    Eide MJ; Weinstock MA; Clark MA
    J Am Acad Dermatol; 2009 Jan; 60(1):51-8. PubMed ID: 18937998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma prognosis in Europe: far from equal.
    Forsea AM; Del Marmol V; Stratigos A; Geller AC
    Br J Dermatol; 2014 Jul; 171(1):179-82. PubMed ID: 24588115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of increased dermatologist density with lower melanoma mortality.
    Aneja S; Aneja S; Bordeaux JS
    Arch Dermatol; 2012 Feb; 148(2):174-8. PubMed ID: 22351816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
    Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
    J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Alvarez E; Keegan T; Johnston EE; Haile R; Sanders L; Saynina O; Chamberlain LJ
    Cancer; 2017 Jul; 123(13):2516-2523. PubMed ID: 28241089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to medical care, dental care, and prescription drugs: the roles of race/ethnicity, health insurance, and income.
    Shi L; Lebrun LA; Tsai J
    South Med J; 2010 Jun; 103(6):509-16. PubMed ID: 20710132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in melanoma survival.
    Dawes SM; Tsai S; Gittleman H; Barnholtz-Sloan JS; Bordeaux JS
    J Am Acad Dermatol; 2016 Nov; 75(5):983-991. PubMed ID: 27476974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
    Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
    J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based geographic access to parent and satellite National Cancer Institute Cancer Center Facilities.
    Onega T; Alford-Teaster J; Wang F
    Cancer; 2017 Sep; 123(17):3305-3311. PubMed ID: 28464212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
    Liss DT; Baker DW
    Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of demographics, socioeconomics, and health care access on melanoma outcomes.
    Cortez JL; Vasquez J; Wei ML
    J Am Acad Dermatol; 2021 Jun; 84(6):1677-1683. PubMed ID: 32783908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities in medical and dental health, access to care, and use of services in US children.
    Flores G; Tomany-Korman SC
    Pediatrics; 2008 Feb; 121(2):e286-98. PubMed ID: 18195000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/Ethnic differences in Medicare experiences and immunization: the role of disease burden.
    Orr N; Elliott MN; Burkhart Q; Haviland A; Weinick RM
    Med Care; 2013 Sep; 51(9):823-31. PubMed ID: 23807592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of primary care provider density on detection and diagnosis of cutaneous melanoma.
    Fleming NH; Grade MM; Bendavid E
    PLoS One; 2018; 13(7):e0200097. PubMed ID: 30005065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to care in an ethnically diverse publicly insured population: is health care reform enough?
    Call KT; McAlpine DD; Garcia CM; Shippee N; Beebe T; Adeniyi TC; Shippee T
    Med Care; 2014 Aug; 52(8):720-7. PubMed ID: 25023917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using SEER data to quantify effects of low income neighborhoods on cause specific survival of skin melanoma.
    Cheung MR
    Asian Pac J Cancer Prev; 2013; 14(5):3219-21. PubMed ID: 23803107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.
    Roetzheim RG; Lee JH; Ferrante JM; Gonzalez EC; Chen R; Fisher KJ; Love-Jackson K; McCarthy EP
    J Am Board Fam Med; 2013; 26(6):637-47. PubMed ID: 24204060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Survival, and Mortality of Malignant Cutaneous Melanoma in Wisconsin, 1995-2011.
    Peterson M; Albertini MR; Remington P
    WMJ; 2015 Oct; 114(5):196-201. PubMed ID: 26726340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s.
    Rigel DS
    Mayo Clin Proc; 1997 Apr; 72(4):367-71. PubMed ID: 9121186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.